These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 215488

  • 1. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
    Omata M, Ashcavai M, Liew CT, Peters RL.
    Gastroenterology; 1979 Feb; 76(2):279-87. PubMed ID: 215488
    [Abstract] [Full Text] [Related]

  • 2. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [Abstract] [Full Text] [Related]

  • 3. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 4. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
    Tanaka H, Iwasaki Y, Nouso K, Kobayashi Y, Nakamura S, Matsumoto E, Toshikuni N, Kaneyoshi T, Ohsawa T, Takaguchi K, Fujio K, Senoh T, Ohnishi T, Sakaguchi K, Shiratori Y.
    J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
    Goeser T, Müller HM, Solbach C, Toex U, Kommerell B, Theilmann L.
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
    [Abstract] [Full Text] [Related]

  • 6. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM, Shrestha S, Shrestha A, Tsuda F, Endo K, Takahashi M, Okamoto H.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [Abstract] [Full Text] [Related]

  • 7. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS.
    Princess Takamatsu Symp; 1995 Sep; 25():27-32. PubMed ID: 8875606
    [Abstract] [Full Text] [Related]

  • 9. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M.
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [Abstract] [Full Text] [Related]

  • 10. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
    Grob PJ.
    Schweiz Med Wochenschr; 1986 Aug 23; 116(34):1133-45. PubMed ID: 3020684
    [Abstract] [Full Text] [Related]

  • 11. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K, Pal NS, Arora SK.
    Indian J Pathol Microbiol; 2006 Jul 23; 49(3):357-61. PubMed ID: 17001884
    [Abstract] [Full Text] [Related]

  • 12. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
    Peters M, Wellek S, Dienes HP, Junginger T, Meyer J, Meyer Zum Büschendfelde KH, Gerken G.
    Z Gastroenterol; 1994 Mar 23; 32(3):146-51. PubMed ID: 8197809
    [Abstract] [Full Text] [Related]

  • 13. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.
    J Gastroenterol Hepatol; 2007 Jul 23; 22(7):1104-11. PubMed ID: 17559381
    [Abstract] [Full Text] [Related]

  • 14. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 Jul 23; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis.
    Yamanaka T, Shiraki K, Nakazaawa S, Okano H, Ito T, Deguchi M, Takase K, Nakano T.
    Anticancer Res; 2001 Jul 23; 21(4B):2937-40. PubMed ID: 11712790
    [Abstract] [Full Text] [Related]

  • 19. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
    Craxi A, Pasqua P, Giannuoli G, Di Stefano R, Simonetti RG, Pagliaro L.
    Hepatogastroenterology; 1984 Apr 23; 31(2):55-9. PubMed ID: 6327478
    [Abstract] [Full Text] [Related]

  • 20. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
    Shim J, Kim BH, Kim NH, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R.
    J Gastroenterol Hepatol; 2005 May 23; 20(5):746-51. PubMed ID: 15853989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.